Stanley A. Plotkin YOU? Author Swipe

Last 10y

Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study Open

John Youhanna, Joan Puig‐Barberà, Matthew S. Miller, Deborah Molrine, Monica Hadi , et al. · 2025

NA is an important influenza vaccine component and is associated with specific benefits. These benefits would likely be greater if NA content were standardised. Additional research is needed to optimise vaccines for anti-NA effects.

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary Open

Deborah King, Helen Groves, Charlie Weller, Ian Jones, Jakob P Cramer , et al. · 2024

Enabling the evaluation of COVID-19 vaccines with correlates of protection Open

Arnaud Marchant, Pierre Van Damme, Stanley A. Plotkin, Pieter Neels, M. Cristina Cassetti , et al. · 2023

In February 2023, a meeting about correlates of protection (CoPs) against COVID-19 was organized by the International Alliance for Biological Standardization, the European Plotkin Institute for Vaccinology, and Vaccinopolis. The meeting ai…

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop Open

Anne Schuind, Helen Rees, John T. Schiller, Nelly Mugo, Peter Dull , et al. · 2023

The burden of cervical cancer is disproportionately distributed globally, with the vast majority of cases occurring in low- and middle-income countries. Women with human immunodeficiency virus (HIV) (WWH) are at increased risk of human pap…

Supp Figure Legends from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Legends

Supp Figures from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Supplemental Figure 1 - Rates of CIN2/3 regression (primary endpoint) or CIN2/3 regression concomitant with clearance of HPV16 and/or HPV18 infection (secondary endpoint) in the Per Protocol population of the Phase IIb study of VGX-3100 fo…

Data from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Purpose: As previously reported, treatment of high-grade cervical dysplasia with VGX-3100 resulted in complete histopathologic regression (CR) concomitant with elimination of HPV16/18 infection in 40.0% of VGX-3100–treated patients …

Supp Figures from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Supplemental Figure 1 - Rates of CIN2/3 regression (primary endpoint) or CIN2/3 regression concomitant with clearance of HPV16 and/or HPV18 infection (secondary endpoint) in the Per Protocol population of the Phase IIb study of VGX-3100 fo…

Data from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Purpose: As previously reported, treatment of high-grade cervical dysplasia with VGX-3100 resulted in complete histopathologic regression (CR) concomitant with elimination of HPV16/18 infection in 40.0% of VGX-3100–treated patients …

Supp Figure Legends from Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Open

Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael J. Dallas, Dawson Knoblock , et al. · 2023

Legends

Vaccine Decision-making in a Time of Conflicting Recommendations: A Call to Go Beyond Politics Open

Daniel A. Salmon, Stanley A. Plotkin, Ann Marie Návar · 2023

Salmon, Daniel A. PhD; Plotkin, Stanley MD; Navar, Ann Marie MD, PhD Author Information

Recent updates on correlates of vaccine-induced protection Open

Stanley A. Plotkin · 2023

Correlates of protection are key for vaccine development against any pathogen. In this paper we summarize recent information about correlates for vaccines against dengue, Ebola, influenza, pneumococcal, respiratory syncytial virus, rotavir…

A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines Open

Peter B. Gilbert, Rubén O. Donis, Richard A. Koup, Youyi Fong, Stanley A. Plotkin , et al. · 2022

The world needs to prepare now to prevent polio resurgence post eradication Open

Amie Batson, Amanda Glassman, Awi Federgruen, Judith Diment, Nirmal Kumar Ganguly , et al. · 2022

Review of: "Lessons from vaccine-related poliovirus in Israel, UK and USA" Open

Stanley A. Plotkin · 2022

a well known polio expert, and his associate Dr. Dharmapalan, have published a strong argument for a change in the strategy of polio eradication.Attempts to eradicate polio have been going on for the last 30 years using attenuated strains …

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation Open

Philip R. Krause, Narendra K. Arora, William C. Dowling, César Muñoz‐Fontela, Simon G. P. Funnell , et al. · 2022

Why We Need Precision Vaccinology Open

Stanley A. Plotkin · 2022

Vaccine development has moved from an empirical origin to the use of antigenic characterization, structural biology, immune function definition, protein synthesis, and precise definition of immune correlates of protection in order to deal …

Serologic Tests for COVID-19 Infections and Vaccination Open

Stanley A. Plotkin · 2022

From the Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Pennsylvania, USA Accepted for publication April 23, 2022 The author has no funding or conflicts of interest to disclose. Address for corre…

Correlates of protection against <span>SARS</span>‐<span>CoV</span>‐2 infection and COVID‐19 disease Open

David Goldblatt, Galit Alter, Shane Crotty, Stanley A. Plotkin · 2022

Antibodies against epitopes in S1 give the most accurate CoP against infection by the SARS‐CoV‐2 coronavirus. Measurement of those antibodies by neutralization or binding assays both have predictive value, with binding antibody titers givi…

Obituary of Robert Daum - Expert in Staphylococcal Disease Open

Stanley A. Plotkin · 2022

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic Open

Asimenia Angelidou, Jay T. Evans, Olubukola T. Idoko, Ofer Levy, Nicole Pignatiello Lewis , et al. · 2022

Correlates of Protection Against SARS CoV-2 Infection and Covid 19 Disease Open

David Goldblatt, Galit Alter, SHane Crotty, Stanley A. Plotkin · 2022

Antibodies against epitopes in S1 of SARS-2 coronavirus give the most accurate correlate of protection against infection. Measurement of those antibodies by neutralization or binding assays have predictive value. However, the protective fu…

The scourge of vaccine falsification Open

Pierre Saliou, Quentin Duteil, Stanley A. Plotkin, M Gentilini · 2022

Evolving measles status and immunization policy development in six European countries Open

Ivo Vojtek, Heidi J. Larson, Stanley A. Plotkin, Pierre Van Damme · 2022

Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured int…

Towards a population-based threshold of protection for COVID-19 vaccines Open

David Goldblatt, Andrew Fiore‐Gartland, Marina Johnson, Adam Hunt, Christopher Bengt , et al. · 2021

Correlates of protection for COVID-19 vaccines are urgently needed to license additional vaccines. We measured immune responses to four COVID-19 vaccines of proven efficacy using a single serological platform. IgG anti-Spike antibodies wer…

The influence of interval between doses on response to vaccines Open

Charlene M.C. Rodrigues, Stanley A. Plotkin · 2021

Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted? Open

Amie Batson, Awi Federgruen, Nirmal Kumar Ganguly, Amanda Glassman, Simba Makoni , et al. · 2021

NIAID workshop on secondary vaccine effects Open

Aaron M. Joffe, Eun-Chung Park, Alison D. Augustine, Chao Jiang, Mercy PrabhuDas , et al. · 2021

A Population-Based Threshold of Protection for COVID-19 Vaccines Open

David Goldblatt, Andrew Fiore‐Gartland, Marina Johnson, Adam Hunt, Christopher Bengt , et al. · 2021

Correlates of protection for COVID-19 vaccines are urgently needed to license and deploy additional vaccines. We measured immune responses to four COVID-19 vaccines of proven efficacy using a single serological platform calibrated to the i…

Evidence for antibody as a protective correlate for COVID-19 vaccines Open

Kristen Earle, Donna M. Ambrosino, Andrew Fiore‐Gartland, David Goldblatt, Peter B. Gilbert , et al. · 2021

Fetching topic information...